Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | +3.11% |
|
+24.81% | -50.15% |
Jul. 02 | Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada | MT |
Jul. 02 | Coherus BioSciences, Inc. Enters into an Exclusive License and Distribution Agreement Apotex, Inc | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.15% | 190M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus Biosciences, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 11